Polyunsaturated fatty acids in multiple sclerosis therapy.

BACKGROUND Results from epidemiological and uncontrolled intervention studies in multiple sclerosis (MS) suggest a beneficial disease-modifying effect of increased intake of polyunsaturated fatty acids (PUFAs). OBJECTIVE To review the current evidence from animal studies and randomised controlled trials on the therapeutic effect of PUFAs in MS. METHODS… CONTINUE READING